Compound 1869
Identifiers
- Canonical SMILES:
Cc1[nH]c(-c2ccccc2Oc2ccccc2)c2cn[nH]c(=O)c12
- IUPAC name:
7-methyl-5-(2-phenoxyphenyl)-1H,2H,6H-pyrrolo[3,4-d]pyridazin-1-one
- InChi:
InChI=1S/C19H15N3O2/c1-12-17-15(11-20-22-19(17)23)18(21-12)14-9-5-6-10-16(14)24-13-7-3-2-4-8-13/h2-11,21H,1H3,(H,22,23)
- InChiKey:
QCLURBBHYMMOOB-UHFFFAOYSA-N
External links
![]() 136387526 |
![]() CHEMBL4102516 |
87M |
External search
![]() |
![]() |
![]() |
![]() |
![]() |
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 2 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
Bromodomain / Histone | 7.43 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 317.12 g/mol | |||
HBA | 5 | |||
HBD | 2 | |||
HBA + HBD | 7 | |||
AlogP | 3.34 | |||
TPSA | 66.48 | |||
RB | 3 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 2 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
10.1016/j.bmcl.2017.02.057 | 27 | BRD4 O60885 |
H4 P62805 |
Biochemical assay | Time-Resolved FRET | pKi (inhibition constant, -log10) | 7.43 | |
10.1016/j.bmcl.2017.02.057 | 27 | BRD4 O60885 |
H4 P62805 |
Cellular assay | MX-1 proliferation assay | MX-1 | pEC50 (half maximal effective concentration, -log10) | 6.74 |
10.1016/j.bmcl.2017.02.057 | 27 | BRD4 O60885 |
H4 P62805 |
Cellular assay | Luciferase reporter | H1299 | pEC50 (half maximal effective concentration, -log10) | 6.66 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.4600 | 4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL | DB07336 | |
0.4518 | 3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE | DB07075 | |
0.4422 | 3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE | DB07229 | |
0.4354 | [2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA | DB07247 | |
0.4328 | 2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine | DB02463 | |
0.4268 | CRA_10433 | DB03173 | |
0.4203 | CRA_8696 | DB03159 | |
0.4167 | CRA_10991 | DB01771 | |
0.4161 | 6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine | DB03865 | |
0.4150 | Zardaverine | DB02918 | |
0.4118 | (5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL | DB07213 | |
0.4088 | [5-(5-Amino-1H-pyrrolo[3,2-b]pyridin-2-yl)-6-hydroxy-3'-nitro-3-biphenylyl]acetic acid | DB08232 | |
0.4082 | CRA_9076 | DB04215 | |
0.4077 | 3-pyridin-4-yl-1H-indazole | DB08113 | |
0.4067 | Irdabisant | DB12900 |